Key points are not available for this paper at this time.
Many patients with Alzheimer's disease experience behavioral and psychological symptoms of dementia (BPSD), which significantly affect their quality of life. It is known that 5-Hydroxytryptamine (5-HT) plays a crucial role in the development of BPSD. However, the relationship between tooth loss and Alzheimer's disease symptoms, particularly aggression, has remained unexplored. Although nutritional status is known to influence the progression of dementia, the specific effect of tooth loss on peripheral symptoms, notably aggression, is not well understood. In our study, we conducted maxillary molar extractions in aged C57BL6J and AppNL-G-F mice and observed their condition over a 3-month period. During this time, we documented significant behavioral and genetic differences between mice in the control groups and mice that underwent tooth extraction. Notably, mice that underwent tooth extraction exhibited a considerable decline in cognitive function and an increase in aggression at 3 months after tooth extraction compared with the control groups (C57BL6J or AppNL-G-Fmice). Our findings suggest that molar loss may lead to reduced 5-HT levels in the hippocampus, possibly mediated by the trigeminal nerve, contributing to the development of aggression and BPSD in Alzheimer's disease. This study sheds light on the intricate relationships between oral health, 5-HT, and Alzheimer's disease symptoms, offering valuable insights into potential therapeutic avenues for managing BPSD in patients with dementia.
Furukawa et al. (Thu,) studied this question.